{"id":242563,"date":"2025-06-18T11:58:16","date_gmt":"2025-06-18T11:58:16","guid":{"rendered":"https:\/\/pharmeasy.in\/blog\/?p=242563"},"modified":"2026-04-06T04:47:21","modified_gmt":"2026-04-06T04:47:21","slug":"is-mounjaro-approved-for-weight-loss-heres-what-our-endocrinologist-says","status":"publish","type":"post","link":"https:\/\/pharmeasy.in\/blog\/is-mounjaro-approved-for-weight-loss-heres-what-our-endocrinologist-says\/","title":{"rendered":"Is Mounjaro Approved for Weight Loss? Here&#8217;s What Our Endocrinologist Says"},"content":{"rendered":"<!DOCTYPE html PUBLIC \"-\/\/W3C\/\/DTD HTML 4.0 Transitional\/\/EN\" \"http:\/\/www.w3.org\/TR\/REC-html40\/loose.dtd\">\n<html><head><meta http-equiv=\"Content-Type\" content=\"text\/html; charset=utf-8\">\n<\/head><body><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_79_2 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-69e9151591c3c\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"ez-toc-cssicon\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-69e9151591c3c\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/pharmeasy.in\/blog\/is-mounjaro-approved-for-weight-loss-heres-what-our-endocrinologist-says\/#Introduction\" >Introduction<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/pharmeasy.in\/blog\/is-mounjaro-approved-for-weight-loss-heres-what-our-endocrinologist-says\/#Is_Mounjaro_Approved_for_Weight_Loss\" >Is Mounjaro Approved for Weight Loss?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/pharmeasy.in\/blog\/is-mounjaro-approved-for-weight-loss-heres-what-our-endocrinologist-says\/#How_Does_Mounjaro_Work\" >How Does Mounjaro Work?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/pharmeasy.in\/blog\/is-mounjaro-approved-for-weight-loss-heres-what-our-endocrinologist-says\/#Who_Is_Mounjaro_Prescribed_For\" >Who Is Mounjaro Prescribed For?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/pharmeasy.in\/blog\/is-mounjaro-approved-for-weight-loss-heres-what-our-endocrinologist-says\/#How_Is_Mounjaro_Taken\" >How Is Mounjaro Taken?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/pharmeasy.in\/blog\/is-mounjaro-approved-for-weight-loss-heres-what-our-endocrinologist-says\/#What_Are_the_Reported_Effects\" >What Are the Reported Effects?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/pharmeasy.in\/blog\/is-mounjaro-approved-for-weight-loss-heres-what-our-endocrinologist-says\/#Mounjaro_Side_Effects\" >Mounjaro Side Effects<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/pharmeasy.in\/blog\/is-mounjaro-approved-for-weight-loss-heres-what-our-endocrinologist-says\/#What_Studies_Say_Mounjaro_and_Weight_Outcomes\" >What Studies Say: Mounjaro and Weight Outcomes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/pharmeasy.in\/blog\/is-mounjaro-approved-for-weight-loss-heres-what-our-endocrinologist-says\/#Mounjaro_Cost_and_Availability\" >Mounjaro Cost and Availability<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/pharmeasy.in\/blog\/is-mounjaro-approved-for-weight-loss-heres-what-our-endocrinologist-says\/#What_to_Know_Before_Using_Mounjaro\" >What to Know Before Using Mounjaro?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/pharmeasy.in\/blog\/is-mounjaro-approved-for-weight-loss-heres-what-our-endocrinologist-says\/#Conclusion\" >Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/pharmeasy.in\/blog\/is-mounjaro-approved-for-weight-loss-heres-what-our-endocrinologist-says\/#Frequently_Asked_Questions_FAQs\" >Frequently Asked Questions (FAQs)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/pharmeasy.in\/blog\/is-mounjaro-approved-for-weight-loss-heres-what-our-endocrinologist-says\/#References\" >References<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Introduction\"><\/span><strong>Introduction<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Mounjaro (<a href=\"https:\/\/pharmeasy.in\/molecules\/tirzepatide-4386906\" target=\"_blank\" rel=\"noreferrer noopener\">tirzepatide<\/a>) is an injectable medication approved in 2024 by the Central Drugs Standard Control Organization (CDSCO) in India, for improving blood sugar management in adults with type 2 diabetes (T2DM), when used in conjunction with diet and exercise<a href=\"https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drug-trials-snapshots-mounjaro\"><sup>1<\/sup><\/a><sup>,<\/sup><a href=\"https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadCommitteeFiles\/Recommendations%20Endocrinology%20%26%20Metabolism%2013.08.2024.pdf\"><sup>2<\/sup><\/a>. Since its approval, <a href=\"https:\/\/pharmeasy.in\/molecules\/tirzepatide-4386906\" target=\"_blank\" rel=\"noreferrer noopener\">tirzepatide<\/a> has earned significant attention not only for its glucose-lowering effects but also for its impact on weight management<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36751934\/\" target=\"_blank\" rel=\"noreferrer noopener\"><sup>3<\/sup><\/a><sup>,<\/sup><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10154650\/\"><sup>4<\/sup><\/a>.\u00a0<\/p>\n\n\n\n<p>This article explores the pharmacologic mechanisms of <a href=\"https:\/\/pharmeasy.in\/molecules\/tirzepatide-4386906\" target=\"_blank\" rel=\"noreferrer noopener\">tirzepatide<\/a>, reviews key clinical findings, examines emerging evidence on its effect on body weight and metabolic health, and considers expert opinions on the medicine.\u00a0<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Is_Mounjaro_Approved_for_Weight_Loss\"><\/span><strong>Is Mounjaro Approved for Weight Loss?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Mounjaro (<a href=\"https:\/\/pharmeasy.in\/molecules\/tirzepatide-4386906\" target=\"_blank\" rel=\"noreferrer noopener\">tirzepatide<\/a>) is currently approved only for the treatment of T2DM. It is not officially approved for weight loss<a href=\"https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drug-trials-snapshots-mounjaro\"><sup>1<\/sup><\/a>.\u00a0<\/p>\n\n\n\n<p>However, in the United States, the Food and Drug Administration (FDA) has approved <a href=\"https:\/\/pharmeasy.in\/molecules\/tirzepatide-4386906\" target=\"_blank\" rel=\"noreferrer noopener\">tirzepatide<\/a> for weight loss under a different brand name known as Zepbound. This brand is specifically used for chronic weight management in adults with obesity or those who are overweight with a minimum of one weight-related condition (such as hypertension)<a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-medication-chronic-weight-management\"><sup>5<\/sup><\/a>.\u00a0<\/p>\n\n\n\n<p>Therefore, to answer the question, \u201cis Mounjaro approved for weight loss?\u201d, while the brand Mounjaro is not approved for weight loss in India, Zepbound (another brand name for <a href=\"https:\/\/pharmeasy.in\/molecules\/tirzepatide-4386906\" target=\"_blank\" rel=\"noreferrer noopener\">tirzepatide<\/a>) is approved in the U.S. for weight management, although not specifically as a weight loss drug.\u00a0<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Does_Mounjaro_Work\"><\/span><strong>How Does Mounjaro Work?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><a href=\"https:\/\/pharmeasy.in\/molecules\/tirzepatide-4386906\" target=\"_blank\" rel=\"noreferrer noopener\">Tirzepatide<\/a> works by stimulating two natural gut hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK585056\/\"><sup>6<\/sup><\/a>. These hormones help regulate blood sugar, insulin levels, and appetite<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11304055\/\"><sup>7<\/sup><\/a>.\u00a0<\/p>\n\n\n\n<p>By activating both GLP-1 and GIP receptors, <a href=\"https:\/\/pharmeasy.in\/molecules\/tirzepatide-4386906\" target=\"_blank\" rel=\"noreferrer noopener\">tirzepatide<\/a>:\u00a0<\/p>\n\n\n\n<ul>\n<li>Enhances insulin secretion when blood sugar is high<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK585056\/\"><sup>6<\/sup><\/a><\/li>\n\n\n\n<li>Reduces glucagon levels, which helps lower glucose production<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11304055\/\"><sup>7<\/sup><\/a>\u00a0<\/li>\n\n\n\n<li>Slows down digestion, helping you feel full longer<a href=\"https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/update-fdas-ongoing-evaluation-reports-suicidal-thoughts-or-actions-patients-taking-certain-type\"><sup>8<\/sup><\/a>\u00a0<\/li>\n\n\n\n<li>Reduces hunger signals, which may lead to changes in eating habits<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10154650\/\"><sup>4<\/sup><\/a>\u00a0<\/li>\n<\/ul>\n\n\n\n<p>These combined effects may support better blood sugar control and may help in weight management. Therefore, for people wondering \u201chow does Mounjaro help you lose weight,\u201d the answer lies in its unique ability to influence both metabolic and appetite-related pathways, leading to reduced appetite and altered eating patterns over time.\u00a0<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Who_Is_Mounjaro_Prescribed_For\"><\/span><strong>Who Is Mounjaro Prescribed For?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Mounjaro is primarily prescribed for adults with T2DM, especially those with insulin resistance who need better blood sugar control<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11228148\/\"><sup>9<\/sup><\/a>.\u00a0<\/p>\n\n\n\n<p>Mounjaro may also be considered for patients who have obesity or metabolic syndrome, where improving insulin sensitivity and managing weight is essential. Although Mounjaro is not officially approved for weight loss in India, weight management plays a key role in managing conditions like T2DM, high blood pressure, and cardiovascular risk<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11228148\/\"><sup>9<\/sup><\/a>. In such cases, Mounjaro may be used strictly under medical supervision to support overall metabolic health and long-term disease management.\u00a0<\/p><div id=\"sfa_container_242563\" class=\"sfa_container\" style=\"display:none\"><div class=\"sfa_overlay\"><\/div><button id=\"sfa_btn_242563\" class=\"sfa_btn\">Show Full Article<\/button><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Is_Mounjaro_Taken\"><\/span><strong>How Is Mounjaro Taken?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Mounjaro is given as an injection (once weekly), usually at the same time each week. It is injected under the skin (subcutaneously) at common injection sites including the stomach or thigh, or upper arm<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215866s000lbl.pdf\"><sup>10<\/sup><\/a>.\u00a0<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"363\" height=\"280\" src=\"https:\/\/blog-images-1.pharmeasy.in\/blog\/production\/wp-content\/uploads\/2025\/06\/18112225\/Screenshot-2025-06-18-165101.webp\" alt=\"how mounjaro is taken\" class=\"wp-image-242663\" srcset=\"https:\/\/blog-images-1.pharmeasy.in\/blog\/production\/wp-content\/uploads\/2025\/06\/18112225\/Screenshot-2025-06-18-165101.webp 363w, https:\/\/blog-images-1.pharmeasy.in\/blog\/production\/wp-content\/uploads\/2025\/06\/18112225\/Screenshot-2025-06-18-165101-150x116.webp 150w\" sizes=\"(max-width: 363px) 100vw, 363px\" \/><\/figure><\/div>\n\n\n<p><strong>Note:<\/strong> It\u2019s important to rotate injection sites each week to avoid irritation<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215866s000lbl.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><sup>10<\/sup><\/a><sup>,<\/sup><a href=\"https:\/\/uk.lilly.com\/metabolic\/assets\/pdf\/mounjaro-patient-booklet.pdf\"><sup>11<\/sup><\/a>.\u00a0<\/p>\n\n\n\n<p>While people often search for the \u201cbest place to inject Mounjaro for weight loss,\u201d the injection site doesn\u2019t influence the effectiveness of the medication as long as the site is rotated every week.\u00a0<\/p>\n\n\n\n<p>Although Mounjaro is not officially approved for weight loss in India, clinical trials have used specific dosing schedules that have had a significant effect on weight<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215866s000lbl.pdf\"><sup>10<\/sup><\/a>. The correct \u201cMounjaro dose for weight loss\u201d should only be determined by a doctor based on the patient\u2019s individual health needs.\u00a0<\/p>\n\n\n\n<p><strong>Additional Note:<\/strong> Always use Mounjaro under medical supervision to ensure safety and effectiveness.\u00a0<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Are_the_Reported_Effects\"><\/span><strong>What Are the Reported Effects?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Patients and clinical studies have reported several noticeable changes while using Mounjaro. Commonly observed effects include:\u00a0<\/p>\n\n\n\n<ul>\n<li>Reduced appetite<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10154650\/\"><sup>4<\/sup><\/a>\u00a0<\/li>\n\n\n\n<li>Feeling full sooner and for longer periods after meals<a href=\"https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/update-fdas-ongoing-evaluation-reports-suicidal-thoughts-or-actions-patients-taking-certain-type\"><sup>8<\/sup><\/a>\u00a0<\/li>\n<\/ul>\n\n\n\n<p>These changes may support improved portion control and less frequent cravings (or snacking), which may eventually support better weight and blood sugar management.\u00a0<\/p>\n\n\n\n<p>However, it\u2019s important to note that these reported effects are not guaranteed. Responses to Mounjaro can vary based on individual factors like lifestyle, medical history, and how the body reacts to treatment. Always consult your doctor for any advice.\u00a0<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Mounjaro_Side_Effects\"><\/span><strong>Mounjaro Side Effects<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>When using Mounjaro for diabetes management, some patients report side effects, especially during the first few weeks as the body adjusts. Commonly noted Mounjaro side effects include<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK585056\/\" target=\"_blank\" rel=\"noreferrer noopener\"><sup>6<\/sup><\/a><sup>,<\/sup><a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215866s000lbl.pdf\"><sup>10<\/sup><\/a>:\u00a0<\/p>\n\n\n\n<ul>\n<li>Nausea\u00a0<\/li>\n\n\n\n<li>Vomiting\u00a0<\/li>\n\n\n\n<li>Constipation\u00a0<\/li>\n\n\n\n<li>Diarrhoea\u00a0<\/li>\n<\/ul>\n\n\n\n<p>Tips to manage the above gastrointestinal side effects of Mounjaro<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9821052\/\"><sup>12<\/sup><\/a>:\u00a0<\/p>\n\n\n\n<ul>\n<li>Eat smaller, lighter meals\u00a0<\/li>\n\n\n\n<li>Avoid greasy or spicy foods\u00a0<\/li>\n\n\n\n<li>Stay well-hydrated\u00a0<\/li>\n\n\n\n<li>Don\u2019t lie down immediately after eating\u00a0<\/li>\n\n\n\n<li>Speak to your doctor if symptoms persist\/worsen\u00a0<\/li>\n<\/ul>\n\n\n\n<p>While many people tolerate Mounjaro well, it\u2019s important to monitor people taking Mounjaro for weight loss for side effects and consult a doctor to ensure safe and effective use.\u00a0<\/p>\n\n\n\n<blockquote class=\"wp-block-quote doc-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>In my experience, when taking Mounjaro, always consult a qualified dietitian or nutritionist to review your diet plan. This helps prevent gastrointestinal discomfort, Hypoglycemia-related dizziness, and other potential complications linked to unbalanced nutrition.<\/p>\n<cite><a href=\"https:\/\/pharmeasy.in\/legal\/editorial-policy\/dr-malavika-athavale-105\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Dr. Malavika Athavale, Consulting Clinical and IBS Nutritionist<\/strong><\/a><\/cite><\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Studies_Say_Mounjaro_and_Weight_Outcomes\"><\/span><strong>What Studies Say: Mounjaro and Weight Outcomes<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Clinical trials, including the SURMOUNT series, have explored the impact of <a href=\"https:\/\/pharmeasy.in\/molecules\/tirzepatide-4386906\" target=\"_blank\" rel=\"noreferrer noopener\">tirzepatide<\/a> (the active ingredient in Mounjaro) on weight management. In these studies, participants who received <a href=\"https:\/\/pharmeasy.in\/molecules\/tirzepatide-4386906\" target=\"_blank\" rel=\"noreferrer noopener\">tirzepatide<\/a> experienced significant weight reduction, depending on the dose and study duration<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK585056\/\" target=\"_blank\" rel=\"noreferrer noopener\"><sup>6<\/sup><\/a><sup>,<\/sup><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10861994\/\"><sup>13<\/sup><\/a>.\u00a0<\/p>\n\n\n\n<p>For example, in SURMOUNT-1, adults with obesity (without diabetes) lost up to 21% of their body weight over 72 weeks<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35658024\/\"><sup>14<\/sup><\/a>.\u00a0<\/p>\n\n\n\n<p>In comparison to other GLP-1 medications, such as semaglutide, Mounjaro showed a greater average reduction in body weight in clinical trials<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38463003\/\"><sup>15<\/sup><\/a>.\u00a0<\/p>\n\n\n\n<p><strong>Important: <\/strong>These outcomes reflect clinical trial data and do not guarantee the same results for everyone. Weight changes depend on individual factors, including adherence to treatment, lifestyle, and overall health.\u00a0<\/p>\n\n\n\n<p><strong><em>Also Read: <a href=\"https:\/\/pharmeasy.in\/blog\/mounjaro-vs-zepbound-differences-uses-side-effects-more\/\" target=\"_blank\" rel=\"noreferrer noopener\">Mounjaro vs Zepbound: Differences, Uses, Side Effects &amp; More<\/a><\/em><\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Mounjaro_Cost_and_Availability\"><\/span><strong>Mounjaro Cost and Availability<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>In India, Mounjaro is available by prescription and is primarily indicated for T2DM. Its price starts from three thousand rupees and can vary based on the dosage and the pharmacy where it\u2019s purchased. Some insurance plans or discount programs may help reduce the cost. It\u2019s best to check with your local pharmacy or insurance provider for specific pricing and coverage details.\u00a0<\/p>\n\n\n\n<p>While many people search for terms like \u201cMounjaro price for weight loss\u201d or \u201chow to get Mounjaro for weight loss,\u201d it\u2019s important to note that the drug is not approved for weight loss in India and its use for weight management should be considered strictly under the guidance of a doctor.\u00a0<\/p>\n\n\n\n<p><strong>Note:<\/strong> Patients are strongly advised to avoid sourcing Mounjaro online without a prescription, as it should only be used under medical supervision to ensure safety and effectiveness.\u00a0<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_to_Know_Before_Using_Mounjaro\"><\/span><strong>What to Know Before Using Mounjaro?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Before starting Mounjaro, it\u2019s important to understand who it\u2019s meant for and when it may not be appropriate:\u00a0<\/p>\n\n\n\n<ul>\n<li><strong>Eligibility: <\/strong>Mounjaro is intended for adults with T2DM and may be considered in certain cases for those with obesity or metabolic syndrome, under medical guidance<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215866s000lbl.pdf\"><sup>10<\/sup><\/a>.\u00a0<\/li>\n\n\n\n<li><strong>Contraindications: <\/strong>It may not be suitable for individuals with a history of medullary thyroid cancer, pancreatitis, or severe gastrointestinal disease. It should also be avoided during pregnancy unless specifically advised<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215866s000lbl.pdf\"><sup>10<\/sup><\/a>.<\/li>\n\n\n\n<li><strong>Medical Supervision:<\/strong> This is not a self-prescribed solution. Thus, dosing, monitoring for side effects, and adjusting therapy must be done under the supervision of a qualified doctor.<\/li>\n<\/ul>\n\n\n\n<p><strong><em>Also Read: <a href=\"https:\/\/pharmeasy.in\/blog\/mounjaro-vs-ozempic-our-endocrinologist-explains-the-difference\/\" target=\"_blank\" rel=\"noreferrer noopener\">Mounjaro vs Ozempic: Our Endocrinologist Explains the Difference<\/a><\/em><\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Mounjaro is an FDA-approved medication for T2DM and, while not officially approved for weight loss in India, some patients have experienced additional metabolic benefits, including changes in appetite and weight.\u00a0<\/p>\n\n\n\n<p>However, it is not a substitute for healthy lifestyle choices. Long-term success in managing diabetes, weight, or related conditions depends on a combination of medical guidance, balanced nutrition, regular physical activity, and consistent follow-up.\u00a0<\/p>\n\n\n\n<p>Always <a href=\"https:\/\/pharmeasy.in\/online-doctor-consultation\/\" target=\"_blank\" rel=\"noreferrer noopener\">consult a doctor<\/a> before starting or continuing any medication like Mounjaro. Remember, safe, supervised use is key to achieving the best outcomes.\u00a0<\/p>\n\n\n\n<p><strong><em>Also Read:<a href=\"https:\/\/pharmeasy.in\/blog\/everything-to-know-about-mounjaro-uses-side-effects-dosage-how-it-works\/\" target=\"_blank\" rel=\"noreferrer noopener\"> Mounjaro (Injection): Uses, Side Effects, Dosage, and How It Works\u00a0<\/a><\/em><\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_FAQs\"><\/span><strong>Frequently Asked Questions (FAQs)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1750230608290\"><strong class=\"schema-faq-question\"><strong>Is Mounjaro approved for weight loss in India?<\/strong>\u00a0<\/strong> <p class=\"schema-faq-answer\">No, Mounjaro (<a href=\"https:\/\/pharmeasy.in\/molecules\/tirzepatide-4386906\" target=\"_blank\" rel=\"noreferrer noopener\">tirzepatide<\/a>) is not approved for weight loss in India; its use is strictly limited to improving glycaemic control in adults with T2DM<a href=\"https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadCommitteeFiles\/Recommendations%20Endocrinology%20%26%20Metabolism%2019.06.2024.pdf\"><sup>16<\/sup><\/a>.\u00a0<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1750230618929\"><strong class=\"schema-faq-question\"><strong>How much weight do people lose with Mounjaro?<\/strong>\u00a0<\/strong> <p class=\"schema-faq-answer\">In clinical trials where the effect of <a href=\"https:\/\/pharmeasy.in\/molecules\/tirzepatide-4386906\" target=\"_blank\" rel=\"noreferrer noopener\">tirzepatide<\/a> was studied in individuals with obesity over 72 weeks:\u00a0<br>-People without diabetes lost up to 20.9% of their body weight (SURMOUNT-1)<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35658024\/\"><sup>14<\/sup><\/a>.\u00a0<br>-People with T2DM lost up to 14.7% (SURMOUNT-2) of body weight<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37385275\/\"><sup>17<\/sup><\/a>.\u00a0<br><strong>Note:<\/strong> These results are based on trial data (individual outcomes may vary).\u00a0<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1750230639700\"><strong class=\"schema-faq-question\"><strong>How do I take Mounjaro safely?<\/strong>\u00a0<\/strong> <p class=\"schema-faq-answer\">Mounjaro should be taken once a week as a subcutaneous injection (under the skin), typically in the stomach, thigh, or upper arm, with rotation of injection sites each time. It must be used under medical supervision, as your doctor will determine the appropriate dose and monitor for side effects<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215866s000lbl.pdf\"><sup>10<\/sup><\/a>. Do not self-prescribe, especially for weight loss; safe use requires professional guidance.\u00a0<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1750230651046\"><strong class=\"schema-faq-question\"><strong>Can I use Mounjaro if I do not have diabetes?<\/strong>\u00a0<\/strong> <p class=\"schema-faq-answer\">In India, Mounjaro is approved only for T2DM<a href=\"https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadCommitteeFiles\/Recommendations%20Endocrinology%20%26%20Metabolism%2019.06.2024.pdf\"><sup>16<\/sup><\/a>. Its use for weight loss in people without diabetes is not officially approved and should only be considered under medical supervision.\u00a0<\/p> <\/div> <\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"References\"><\/span><strong>References<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ol>\n<li>U.S. Food and Drug Administration. Drug Trials Snapshots: MOUNJARO. U.S. Department of Health and Human Services. [cited 2025 Jun 16]. Available from:<a href=\"https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drug-trials-snapshots-mounjaro\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drug-trials-snapshots-mounjaro<\/a>\u00a0<\/li>\n\n\n\n<li>Central Drugs Standard Control Organisation (CDSCO). Recommendations of the Subject Expert Committee (Endocrinology &amp; Metabolism) meeting held on 13 August 2024 [Internet]. New Delhi: CDSCO; 2024 Aug 13 [cited 2025 Jun 17]. Available from:<a href=\"https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadCommitteeFiles\/Recommendations%20Endocrinology%20%26%20Metabolism%2013.08.2024.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadCommitteeFiles\/Recommendations%20Endocrinology%20%26%20Metabolism%2013.08.2024.pdf<\/a>\u00a0<\/li>\n\n\n\n<li>Gettman L. New Drug: Tirzepatide (Mounjaro\u2122). Sr Care Pharm. 2023 Feb 1;38(2):50-62. Available from:<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36751934\/\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/pubmed.ncbi.nlm.nih.gov\/36751934\/<\/a>\u00a0<\/li>\n\n\n\n<li>Heise T, DeVries JH, Urva S, Li J, Pratt EJ, Thomas MK, Mather KJ, Karanikas CA, Dunn J, Haupt A, Milicevic Z, Coskun T. Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes. Diabetes Care. 2023 May 1;46(5):998-1004. Available from:<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10154650\/\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10154650\/<\/a>\u00a0<\/li>\n\n\n\n<li>U.S. Food and Drug Administration. FDA approves new medication for chronic weight management. FDA. 2023; [cited 2025 Jun 16]. Available from:<a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-medication-chronic-weight-management\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-medication-chronic-weight-management<\/a>\u00a0<\/li>\n\n\n\n<li>Farzam K, Patel P. Tirzepatide [Internet]. StatPearls Publishing. 2025; [cited 2025 Jun 09]. Available from:<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK585056\/\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK585056\/<\/a>\u00a0<\/li>\n\n\n\n<li>Liu QK. Mechanisms of action and therapeutic applications of GLP-1 and dual GIP\/GLP-1 receptor agonists. Front Endocrinol (Lausanne). 2024 Jul 24;15:1431292. Available from:<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11304055\/\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11304055\/<\/a>\u00a0<\/li>\n\n\n\n<li>U.S. Food and Drug Administration. Update on FDA\u2019s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type\u202f2 diabetes and obesity. Department of Health and Human Services. [cited 2025 Jun 16]. Available from:<a href=\"https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/update-fdas-ongoing-evaluation-reports-suicidal-thoughts-or-actions-patients-taking-certain-type\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/update-fdas-ongoing-evaluation-reports-suicidal-thoughts-or-actions-patients-taking-certain-type<\/a>\u00a0<\/li>\n\n\n\n<li>Corrao S, Pollicino C, Maggio D, Torres A, Argano C. Tirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence. Front Endocrinol (Lausanne). 2024 Jun 24;15:1402583. Available from:<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11228148\/\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11228148\/<\/a>\u00a0<\/li>\n\n\n\n<li>U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection, for subcutaneous use: Highlights of prescribing information. FDA. 2022; [cited 2025 Jun 09]. Available from:<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215866s000lbl.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215866s000lbl.pdf<\/a>\u00a0<\/li>\n\n\n\n<li>Eli Lilly and Company. Mounjaro Patient Booklet: patient guide to tirzepatide and the KwikPen device<em>.<\/em> March 2025; [cited 2025 Jun 16]. Available from:<a href=\"https:\/\/uk.lilly.com\/metabolic\/assets\/pdf\/mounjaro-patient-booklet.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/uk.lilly.com\/metabolic\/assets\/pdf\/mounjaro-patient-booklet.pdf<\/a>\u00a0<\/li>\n\n\n\n<li>Gorgojo-Mart\u00ednez JJ, Mezquita-Raya P, Carretero-G\u00f3mez J, Castro A, Cebri\u00e1n-Cuenca A, de Torres-S\u00e1nchez A, Garc\u00eda-de-Lucas MD, N\u00fa\u00f1ez J, Obaya JC, Soler MJ, G\u00f3rriz JL, Rubio-Herrera M\u00c1. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. J Clin Med. 2022 Dec 24;12(1):145. Available from:<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9821052\/\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9821052\/<\/a>\u00a0<\/li>\n\n\n\n<li>Jensen TL, Br\u00f8nden A, Karstoft K, Sonne DP, Christensen MB. The Body weight Reducing Effects of Tirzepatide in People with and without Type 2 Diabetes: A Review on Efficacy and Adverse Effects. Patient Prefer Adherence. 2024 Feb 8;18:373-382. Available from:<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10861994\/\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10861994\/<\/a>\u00a0<\/li>\n\n\n\n<li>Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A; SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216. Available from:<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35658024\/\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/pubmed.ncbi.nlm.nih.gov\/35658024\/<\/a>\u00a0<\/li>\n\n\n\n<li>M\u00fcllertz ALO, Sandsdal RM, Jensen SBK, Torekov SS. Potent incretin-based therapy for obesity: A systematic review and meta-analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety. Obes Rev. 2024 May;25(5):e13717. Available from:<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38463003\/\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/pubmed.ncbi.nlm.nih.gov\/38463003\/<\/a>\u00a0<\/li>\n\n\n\n<li>Central Drugs Standard Control Organisation. SEC (Endocrinology &amp; Metabolism) meeting recommendations dated 19 June 2024. Recommendations of the SEC (Endocrinology &amp; Metabolism). New Delhi: CDSCO; 2024 Jun 19. Available from:<a href=\"https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadCommitteeFiles\/Recommendations%20Endocrinology%20%26%20Metabolism%2019.06.2024.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadCommitteeFiles\/Recommendations%20Endocrinology%20%26%20Metabolism%2019.06.2024.pdf<\/a>\u00a0\u00a0<\/li>\n\n\n\n<li>Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, Mao H, Zhang S, Ahmad NN, Bunck MC, Benabbad I, Zhang XM; SURMOUNT-2 investigators. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2023 Aug 19;402(10402):613-626. Available from:<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37385275\/\" target=\"_blank\" rel=\"noreferrer noopener\"> https:\/\/pubmed.ncbi.nlm.nih.gov\/37385275\/<\/a>\u00a0<\/li>\n<\/ol>\n\n\n\n<p><strong><em>Disclaimer<\/em><\/strong><em>: The information provided here is for educational\/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.<\/em><\/p>\n<\/body><\/html>\n<div class=\"pld-like-dislike-wrap pld-custom\">\r\n    <div class=\"pld-like-wrap  pld-common-wrap\">\r\n    <a href=\"javascript:void(0)\" class=\"pld-like-trigger pld-like-dislike-trigger  \" title=\"Likes\" data-post-id=\"242563\" data-trigger-type=\"like\" data-restriction=\"cookie\" data-already-liked=\"0\">\r\n                            <img src=\"https:\/\/blog-images-1.pharmeasy.in\/blog\/production\/wp-content\/uploads\/2024\/08\/12132143\/like.png\" alt=\"Likes\" \/>\r\n            <\/a>\r\n    <span class=\"pld-like-count-wrap pld-count-wrap\">    <\/span>\r\n<\/div><div class=\"pld-dislike-wrap  pld-common-wrap\">\r\n    <a href=\"javascript:void(0)\" class=\"pld-dislike-trigger pld-like-dislike-trigger  \" title=\"Dislikes\" data-post-id=\"242563\" data-trigger-type=\"dislike\" data-restriction=\"cookie\" data-already-liked=\"0\">\r\n                            <img src=\"https:\/\/blog-images-1.pharmeasy.in\/blog\/production\/wp-content\/uploads\/2024\/08\/12132208\/dislike.png\" alt=\"Dislikes\" \/>\r\n            <\/a>\r\n    <span class=\"pld-dislike-count-wrap pld-count-wrap\"><\/span>\r\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"Introduction Mounjaro (tirzepatide) is an injectable medication approved in 2024 by the Central Drugs Standard Control Organization (CDSCO) in India, for improving blood sugar management in adults with type 2 diabetes (T2DM), when used in conjunction with diet and exercise1,2. Since its approval, tirzepatide has earned significant attention not only for its glucose-lowering effects but [\u2026]","protected":false},"author":173,"featured_media":242633,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_wp_rev_ctl_limit":""},"categories":[1547,14037],"tags":[13789,12187],"acf":[],"_embedded":{"wp:featuredmedia":[{"source_url":"https:\/\/blog-images-1.pharmeasy.in\/blog\/production\/wp-content\/uploads\/2025\/06\/18105303\/2-3.webp"}]},"_links":{"self":[{"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/posts\/242563"}],"collection":[{"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/users\/173"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/comments?post=242563"}],"version-history":[{"count":64,"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/posts\/242563\/revisions"}],"predecessor-version":[{"id":274629,"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/posts\/242563\/revisions\/274629"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/media\/242633"}],"wp:attachment":[{"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/media?parent=242563"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/categories?post=242563"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmeasy.in\/blog\/wp-json\/wp\/v2\/tags?post=242563"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}